Pfizer Inc - Company Profile
Powered by
All the data and insights you need on Pfizer Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Pfizer Inc Strategy Report
- Understand Pfizer Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreView up-to-date information on Pfizer Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP4058061A1 | Application | STABILE WÄSSRIGE ANTI-TAU-ANTIKÖRPERFORMULIERUNG | A61K39/39591; A61K47/10; A61K47/12; A61K47/183; A61K47/22; A61K47/26; A61K9/08; A61P7/04; C07K16/38; C07K2317/31; C07K2317/76 | September 21, 2022 |
EP4057989A1 | Application | 1-(((2S,3S,4S)-3-ETHYL-4-FLUOR-5-OXOPYRROLIDIN-2-YL)METHOXY)-7-METHOXYISOCHINOLIN-6-CARBOXAMID KOMBINATIONEN UND ORALE DOSIERUNGSFORMEN | A61K2300/00; A61K31/4725; A61K31/519; A61K9/0004; A61K9/2018; A61K9/2054; A61K9/2866; A61P17/10; A61P19/02; A61P29/00 | September 21, 2022 |
EP3464292B1 | Grant | MODULATOREN DES BETA-3-ADRENERGEN REZEPTORS DIE SICH FÜR DIE BEHANDLUNG ODER PRÄVENTION VON DAMIT IN ZUSAMMENHANG STEHENDEN ERKRANKUNGEN EIGNEN | A61K31/438; A61K31/4525; A61K31/4709; A61K31/5383; A61K45/06; A61P9/00; A61P9/04; A61P9/10; C07D491/107; C07D498/04 | September 21, 2022 |
EP3385252B1 | Grant | CANNABINOID-REZEPTOR-MODULATOREN | A61K31/13; A61K31/416; A61K31/4439; A61K31/485; A61K31/497; A61K31/675; A61K45/06; A61P1/02; A61P13/12; A61P17/00; A61P19/00; A61P19/02; A61P25/04; A61P25/06; A61P29/00; A61P3/10; A61P31/18; A61P35/00; A61P37/00; A61P43/00; A61P9/12; C07D231/54; C07D401/04; C07D401/14; C07D403/04; C07D405/14; C07F9/65583 | September 21, 2022 |
CN115066242A | Application | 治疗与S1P1受体相关的病症的方法 | A61K31/404; A61K9/2018; A61K9/2054; A61K9/2059; A61P9/00 | September 16, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward